Improvement of Care & Outcome
Cardiovascular disease (CVD) is the main co-morbidity and cause of mortality in T1D. Although treatments to combat CVD, mainly lipid-lowering and anti-hypertensive medication (LLM and AHM, respectively), have much improved, an excess of CVD morbidity and mortality in T1D still exists. To improve care for and self-management by people with T1D (PWDs), it is necessary to assess if they are reaching blood pressure and low-density lipoprotein-cholesterol (LDL-c) target values. Percentages of PWDs reaching target values vary widely in the literature. This study, co-authored by Erwin Birnie, Dick Mul and Henk-Jan Aanstoot of Diabeter, aimed to assess the percentage of PWDs achieving target values of HbA1c, LDL-c and blood pressure.
In this cross-sectional record review study, data were collected from 1,737 people with T1D (PWDs) visiting Diabeter and the University Medical Center Groningen (UMCG). Demographic, anthropomorphic, laboratory and medication data and data on diabetes-related complications was extracted from electronic medical records for the period 1-1-2018 to 31-12-2018.
Concluding, the authors state